The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Corcept Therapeutics Incorporated(NASDAQ:CORT) 
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia second...
Website: http://www.corcept.com
Founded: 1998
Full Time Employees: 206
Sector: Healthcare
Industry: Biotechnology
Corcept Therapeutics Days Payable Outstanding ttm (DPO)
Corcept Therapeutics Days Receivable Outstanding ttm (DSO)
Corcept Therapeutics Days Inventory Outstanding ttm (DIO)
Corcept Therapeutics Op Cashflow Per Share ttm
Corcept Therapeutics Free Cashflow Per Share ttm
Corcept Therapeutics Cash Per Share ttm
Corcept Therapeutics P/S ratio ttm
Corcept Therapeutics (GAAP) P/E ratio ttm
Corcept Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.